ZIMMER BIOMET HOLDINGS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Cost of Goods Sold (Deprecated 2018-01-31) of $583.70 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-08-06
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $583.70M, a 10.61% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $575.80M, a 12.26% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $591.40M, a 4.89% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $500.90M, a 4.51% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $2.13B, a 10.45% decline from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $2.38B, a 32.28% increase from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $1.80B, a 44.88% increase from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $1.24B, a 1.89% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-06-30 | $583.70M 10-Q · filed 2018-08-06 | $1.16B 10-Q · filed 2018-08-06 | $1.75B derived: sum of 3 quarters · filed 2018-08-06 | $2.25B derived: sum of 4 quarters · filed 2018-08-06 | |||
| 2018-03-31 | $575.80M 10-Q · filed 2018-05-08 | $1.17B derived: sum of 2 quarters · filed 2018-05-08 | $1.67B derived: sum of 3 quarters · filed 2018-05-08 | $2.20B derived: sum of 4 quarters · filed 2018-08-06 | |||
| 2017-12-31 | $591.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.09B derived: sum of 2 quarters · filed 2018-02-27 | $1.62B derived: sum of 3 quarters · filed 2018-08-06 | $2.13B 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $500.90M 10-Q · filed 2017-11-06 | $1.03B derived: sum of 2 quarters · filed 2018-08-06 | $1.54B 10-Q · filed 2017-11-06 | $2.16B derived: sum of 4 quarters · filed 2018-08-06 | |||
| 2017-06-30 | $527.70M 10-Q · filed 2018-08-06 | $1.04B 10-Q · filed 2018-08-06 | $1.66B derived: sum of 3 quarters · filed 2018-08-06 | $2.14B derived: sum of 4 quarters · filed 2018-08-06 | |||
| 2017-03-31 | $512.90M 10-Q · filed 2018-05-08 | $1.13B derived: sum of 2 quarters · filed 2018-05-08 | $1.61B derived: sum of 3 quarters · filed 2018-05-08 | $2.25B derived: sum of 4 quarters · filed 2018-05-08 | |||
| 2016-12-31 | $621.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.10B derived: sum of 2 quarters · filed 2018-02-27 | $1.74B derived: sum of 3 quarters · filed 2018-02-27 | $2.38B 10-K · filed 2018-02-27 | |||
| 2016-09-30 | $479.30M 10-Q · filed 2017-11-06 | $1.12B derived: sum of 2 quarters · filed 2017-11-06 | $1.76B 10-Q · filed 2017-11-06 | $2.43B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $640.10M 10-Q · filed 2017-08-08 | $1.28B 10-Q · filed 2017-08-08 | $1.95B derived: sum of 3 quarters · filed 2018-02-27 | $2.50B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $640.60M 10-Q · filed 2017-05-09 | $635.20M 10-Q · filed 2016-05-10 | $1.31B derived: sum of 2 quarters · filed 2018-02-27 | $1.86B derived: sum of 3 quarters · filed 2018-02-27 | $2.16B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $669.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.22B derived: sum of 2 quarters · filed 2018-02-27 | $1.52B derived: sum of 3 quarters · filed 2018-02-27 | $1.80B 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $552.10M 10-Q · filed 2016-11-08 | $846.40M derived: sum of 2 quarters · filed 2016-11-08 | $1.13B 10-Q · filed 2016-11-08 | $1.44B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $294.30M 10-Q · filed 2016-08-08 | $290.50M 10-Q · filed 2015-08-10 | $579.20M 10-Q · filed 2016-08-08 | $569.20M 10-Q · filed 2015-08-10 | $885.10M derived: sum of 3 quarters · filed 2017-03-01 | $1.18B derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $284.90M 10-Q · filed 2016-05-10 | $278.70M 10-Q · filed 2015-05-07 | $590.80M derived: sum of 2 quarters · filed 2017-03-01 | $889.10M derived: sum of 3 quarters · filed 2017-03-01 | $1.22B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $305.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $604.20M derived: sum of 2 quarters · filed 2017-03-01 | $935.80M derived: sum of 3 quarters · filed 2017-03-01 | $1.24B 10-K · filed 2017-03-01 | $1.25B 10-K · filed 2015-02-23 | ||
| 2014-09-30 | $298.30M 10-Q · filed 2014-11-05 | $629.90M derived: sum of 2 quarters · filed 2015-08-10 | $936.90M 10-Q · filed 2014-11-05 | $1.25B derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $331.60M 10-Q · filed 2015-08-10 | $333.20M 10-Q · filed 2014-08-07 | $635.30M 10-Q · filed 2015-08-10 | $638.60M 10-Q · filed 2014-08-07 | $956.70M derived: sum of 3 quarters · filed 2016-02-29 | $1.29B derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $303.70M 10-Q · filed 2015-05-07 | $305.40M 10-Q · filed 2014-05-06 | $625.10M derived: sum of 2 quarters · filed 2016-02-29 | $953.90M derived: sum of 3 quarters · filed 2016-02-29 | $1.28B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $321.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $650.20M derived: sum of 2 quarters · filed 2016-02-29 | $973.80M derived: sum of 3 quarters · filed 2016-02-29 | $1.27B 10-K · filed 2016-02-29 | $1.29B 10-K · filed 2014-02-28 | ||
| 2013-09-30 | $328.80M 10-Q · filed 2014-11-05 | $652.40M derived: sum of 2 quarters · filed 2014-11-05 | $945.30M 10-Q · filed 2014-11-05 | $1.24B derived: sum of 4 quarters · filed 2015-02-23 | |||
| 2013-06-30 | $323.60M 10-Q · filed 2014-08-07 | $616.50M 10-Q · filed 2014-08-07 | $915.40M derived: sum of 3 quarters · filed 2015-02-23 | $1.17B derived: sum of 4 quarters · filed 2015-02-23 | |||
| 2013-03-31 | $292.90M 10-Q · filed 2014-05-06 | $591.80M derived: sum of 2 quarters · filed 2015-02-23 | $847.50M derived: sum of 3 quarters · filed 2015-02-23 | $1.13B derived: sum of 4 quarters · filed 2015-02-23 | |||
| 2012-12-31 | $298.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $554.60M derived: sum of 2 quarters · filed 2015-02-23 | $836.50M derived: sum of 3 quarters · filed 2015-02-23 | $1.13B 10-K · filed 2015-02-23 | |||
| 2012-09-30 | $255.70M 10-Q · filed 2013-11-12 | $537.60M derived: sum of 2 quarters · filed 2013-11-12 | $826.30M 10-Q · filed 2013-11-12 | $1.13B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-06-30 | $281.90M 10-Q · filed 2013-08-07 | $570.60M 10-Q · filed 2013-08-07 | $873.80M derived: sum of 3 quarters · filed 2014-02-28 | $1.13B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2012-03-31 | $288.70M 10-Q · filed 2013-05-08 | $591.90M derived: sum of 2 quarters · filed 2014-02-28 | $843.80M derived: sum of 3 quarters · filed 2014-02-28 | $1.13B derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $303.20M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $555.10M derived: sum of 2 quarters · filed 2014-02-28 | $843.00M derived: sum of 3 quarters · filed 2014-02-28 | $1.12B 10-K · filed 2014-02-28 | |||
| 2011-09-30 | $251.90M 10-Q · filed 2012-11-06 | $539.80M derived: sum of 2 quarters · filed 2012-11-06 | $818.80M 10-Q · filed 2012-11-06 | $1.09B derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-06-30 | $287.90M 10-Q · filed 2012-08-07 | $566.90M 10-Q · filed 2012-08-07 | $841.00M derived: sum of 3 quarters · filed 2013-02-27 | $1.06B derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2011-03-31 | $279.00M 10-Q · filed 2012-05-03 | $553.10M derived: sum of 2 quarters · filed 2013-02-27 | $772.20M derived: sum of 3 quarters · filed 2013-02-27 | $1.02B derived: sum of 4 quarters · filed 2013-02-27 | |||
| 2010-12-31 | $274.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $493.20M derived: sum of 2 quarters · filed 2013-02-27 | $743.80M derived: sum of 3 quarters · filed 2013-02-27 | $1.01B 10-K · filed 2013-02-27 | |||
| 2010-09-30 | $219.10M 10-Q · filed 2011-11-02 | $469.70M derived: sum of 2 quarters · filed 2011-11-02 | $738.10M 10-Q · filed 2011-11-02 | ||||
| 2010-06-30 | $250.60M 10-Q · filed 2011-08-08 | $519.00M 10-Q · filed 2011-08-08 | |||||
| 2009-12-31 | $990.70M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |